EP0258422A1 - Immunomodulator for improving commercial performance of domestic animals - Google Patents

Immunomodulator for improving commercial performance of domestic animals

Info

Publication number
EP0258422A1
EP0258422A1 EP87901996A EP87901996A EP0258422A1 EP 0258422 A1 EP0258422 A1 EP 0258422A1 EP 87901996 A EP87901996 A EP 87901996A EP 87901996 A EP87901996 A EP 87901996A EP 0258422 A1 EP0258422 A1 EP 0258422A1
Authority
EP
European Patent Office
Prior art keywords
kic
feed
animals
cattle
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP87901996A
Other languages
German (de)
French (fr)
Other versions
EP0258422A4 (en
Inventor
Steven L. Nissen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Iowa Research Foundation UIRF
Iowa State University Research Foundation ISURF
Original Assignee
University of Iowa Research Foundation UIRF
Iowa State University Research Foundation ISURF
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/838,356 external-priority patent/US4758593A/en
Priority claimed from US06/838,357 external-priority patent/US4760090A/en
Priority claimed from US06/838,355 external-priority patent/US4764531A/en
Application filed by University of Iowa Research Foundation UIRF, Iowa State University Research Foundation ISURF filed Critical University of Iowa Research Foundation UIRF
Publication of EP0258422A4 publication Critical patent/EP0258422A4/en
Publication of EP0258422A1 publication Critical patent/EP0258422A1/en
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/70Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75Feeding-stuffs specially adapted for particular animals for birds for poultry
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/105Aliphatic or alicyclic compounds
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/10Feeding-stuffs specially adapted for particular animals for ruminants

Definitions

  • the field of this invention is methods for improving the commercial performance of domestic animals.
  • the invention is particularly concerned with the administration of alphaketoisocaproate (KIC) to domestic animals for improving the immune and/or metabolic functions of the animals.
  • KIC alphaketoisocaproate
  • Keto analogs of essential amino acids have been proposed for use in human nutrition as partial or complete substitutes for the corresponding amino acids, including, for example, leucine, isoleucine, methionine, phenylalanine, and valine.
  • leucine leucine
  • isoleucine methionine
  • phenylalanine and valine.
  • the use of such keto analogs was proposed by Dr. MacKenzie Walser as supplementation to protein-reduced diets in uremia. See, for example, Walser, et al., J. Clin. Inv. (1973) 52:678-690.
  • Further experiments by Walser and associates demonstrated a nitrogen sparing effect from mixtures of branched-chain keto acids. Saiper and Walser, Metabolism (1977) 26:301-308.
  • Patents have issued to Walser on the use of keto analogs of essential amino acids for promotion of protein synthesis and suppression of urea formation in humans.
  • U.S. patents 4,100,161 and 4,101,293 A recent review summarized existing knowledge with respect to the administration of branched-chain keto acids to humans. "New Aspects of Clinical Nutrition", pp. 319-324 (Karger, Basel, 1983).
  • KIC alpha-ketoisocaproate
  • KIC has not been heretofore known as an immunomodulator in humans or animals, nor has it been suggested that KIC can be used to reduce plasma cortisol (hydrocortisone), or that it can be used to favorably alter immune function by enhancing blastogenesis of T lymphocytes.
  • T lymphocytes have important functions in immunological defense against microorganisms. See, for example, Williams et al., "Hematology", Chap. 102, pages 927-928 (2nd Ed., 1977, McGraw-Hill). In their immune function, T lymphocytes, which are normally quiescent, undergo mitosis with accelerated DNA production. Williams, et al., above cited, pages 882-884. This process of T lymphocyte activation is known as blastogenesis. The degree of blastogenesis activation of T lymphocytes can be determined in vitro using mitogens. The most commonly employed mitogens for this purpose are phytohemagglutin (PHA), pokeweed mitogen (PWM), and concanavalin A (conA). Williams et al., citedabove, pages 895, and 923.
  • PHA phytohemagglutin
  • PWM pokeweed mitogen
  • conA concanavalin A
  • the present invention provides a novel method and novel feed compositions for improving the commercial performance of domestic animals.
  • the method utilizes alpha-ketoisocaproate (KIC) as an immunomodulator for improving immune function, and/or as a nutrient additive for improving metabolic function.
  • KIC alpha-ketoisocaproate
  • the administration of KIC favorably alters immune function, as evidenced by enhanced blastogenesis of the T lymphocytes.
  • a further effect on immune function is the marked reduction of plasma cortisol.
  • the enhancement of lymphocyte blastogenesis is of value in increasing disease resistance. Reduced plasma cortisol is expected to be ameliorating in counteracting stress associated immunodepression in domestic animals, and should be useful for controlling cattle shipping fever.
  • KIC-containing feeds In the case of animals being raised for meat production, such as young cattle and sheep, young chickens, and veal calves, KIC can be used as a "growth promotant immunomodulator"--an unprecedented kind of feed additive.
  • Improved metabolic function can also be obtained with mature animals, including dairy cattle, wool-producing sheep, and laying chickens.
  • the production of milk, wool, and eggs can be improved, while at the same time increasing the disease resistance of the animals.
  • nursing domestic mammals such as cattle, sheep, and hogs
  • the improvement in the quality and quantity of the milk benefits the offspring.
  • a further benefit is that the nursing mother mammals are more disease resistant.
  • KIC KIC to cattle prior to shipment
  • the administration of KIC to cattle prior to shipment is expected to mitigate the stress-related effects of shipping fever.
  • the KIC should be in a nutritionally-utilizable form.
  • the KIC should be absorbable in the digestive system, while for parenteral administration a water-soluble form is preferred.
  • it may be used in its free acid form, but its sodium, potassium, ammonium, or calcium salts are preferred.
  • Ammonium and alkali metal salts are more water-soluble, while alkaline earth metal salts such as calcium salt are less water-soluble.
  • KIC Alpha-ketoisocaproate
  • Sodium and calcium salts of KIC as supplied commercially are substantially pure compounds and are in the form of dry powders. However, high purity is not necessarily required for the purposes of the present invention.
  • KIC powders can be mixed with dry feeds, or for non-ruminant mammals and poultry water-soluble KIC salts can be administered by dissolving in drinking water.
  • parenteral administration such as intramuscular injection
  • sodium KIC can be dissolved in a sterile water.
  • feed use to assure administration at a desired level, it is preferred to mix the dry KIC salt with the dry feed ingredients at a predetermined concentration.
  • the KIC salt can be incorporated by dry blending using standard mixing equipment.
  • the KIC should be substantially uniformly distributed throughout the feed. After mixing, if desired, the feed material may be further processed, such as by conversion to pellets.
  • feed compositions are composed of mixtures of feed ingredients.
  • Such mixed feed compositions may comprise complete feeds or feed concentrates. It has been found preferable in promoting metabolic function with KIC to use only limited quantities of proteinaceous feed ingredients which are high in leucine content.
  • feed ingredients include blood meals, which may contain 16 to 20% leucine, and corn gluten meal containing 18 to 20% leucine (based on the protein dry weight).
  • soybean meal contains only about 8 to 9% leucine, and can therefore be used as a carrier for KIC in the form of a protein supplement.
  • the amount of leucine in the diet is not over 12% of the dry weight of the total protein being consumed by the animal.
  • the amount of protein can be calculated by determining nitrogen and multi plying by a standard conversion factor of 6.25 (viz. N x (6.25).
  • the amount of leucine is limited to less than 10% by weight of total protein. Consequently, in the formulation of complete feeds or feed concentrates which are to provide a major portion of the animal's diet, it is preferred to maintain the leucine content of the feed composition to not over 12% and preferably less than 10% (based on total protein).
  • the immune function improvement of KIC can still be obtained at higher leucine levels.
  • the method of this invention can comprise orally administering from as low as 0.5 to 2 milligrams (mg) up to as much as 500 to 1000 mg of alpha-ketoisocaproate (KIC) per kilogram of body weight per 24 hours (hrs).
  • KIC alpha-ketoisocaproate
  • the amount of KIC administered to the animals can range from 1 to 100 mg (Na KIC basis ) per kg body weight per 24 hrs.
  • the amounts of KIC should be understood to relate to the sodium salt of KIC as the weight basis, or to a molar equivalent amount of the calcium salt or other salts or derivatives, which are nutritionably absorbable and utilizable.
  • the amount of KIC may be specified in relation to the feed composition.
  • the admixed feed composition may contain from as low as 0.01 to 0.1 up to 1.5 to 2.0 wt % KIC (Na KIC dry feed weight basis).
  • Such feed compositions will usually contain at least 10% protein and may contain up to 24% protein N x 6.25).
  • KIC tablets may be coated with animal blood or with corn protein (zein).
  • zein corn protein
  • Other proteins can be employed as coating materials which are resistant to rumen breakdown.
  • Polymer coating may also be used such as those known to protect protein against rumen destruction. (See the rumen-protective coatings described in the U.S. Patents 4,181,708, 4,181,709, and 4,181,710).
  • the coating employed should be one which is resistant to the mildly acid environment of the rumen while dissolving in the more acid environment of the abomasum.
  • the amount of KIC required can be monitored by increasing the dosage until an appreciable reduction in plasma cortisol is observed.
  • a useful range is from 1 to 100 mg KIC per kg body weight per 24 hrs (Na KIC basis).
  • the amount administered can be from 2 to 50 mg KIC per kg body weight per 24 hours (NaKIC basis).
  • Feed compositions containing such rumen-protected KIC and comprising substantially the entire diet of the ruminants may contain 0.1 to 0.5% KIC (NaKIC and feed dry weight basis). If unprotected KIC is used these amounts should be increased by a factor of 9 to 10.
  • KlC-feeding is especially useful in the feeding of female and castrated and intact male cattle and sheep, but it can also be used with male ruminants if raised for meat production.
  • Other uses include breeding stock and replacements.
  • the method is preferably used with steers and heifers for beef production, and with wethers, rams, and ewes for lamb meat production and/or wool production.
  • improvements in meat production in relation to protein intake and/or increased wool production can be obtained.
  • With mature sheep which are primarily being raised for wool production the benefit of increased wool production in relation to protein intake is especially valuable.
  • an additional advantage can be reducing the cholesterol content of lean meat, and also probably improving carcass quality or grade.
  • improvement in T lymphocyte function is obtainable.
  • This invention is also usable with calves being raised for veal production.
  • veal calves are not ruminants. They are suckling calves which remain monogastric, i.e., they do not develop a rumen, being fed milk or a milk substitute which provides a balanced diet for the veal calves. KIC fed to veal calves is therefore not subject to rumen loss.
  • a liquid milk replacer for veal calves may contain from 0.01 to 0.5% (NAKIC basis) KIC based on the dry matter content of the milk replacer, and preferably from 0.01 to 0.5% KIC on the same basis.
  • Sodium KIC is preferred because of its water solubility. The limitations on leucine in the diets for the veal calves are preferably observed, as previously described. Lactating Domestic Mammals
  • the method and feed compositions of this invention are applicable to dairy cattle being managed for commercial milk production, and the method and feed compositions can also be advantageously used with lactating goats fed for commercial milk production.
  • the invention provides a means for improving the milk produced by nursing mammals, including cattle, sheep, goats, horses, and swine. The young mammals being nursed thereby obtain the benefits of greater milk production and increased butterfat content. All of the foregoing instructions about the form and amount of KIC are applicable.
  • the feeds employed can be adapted for the particular animal and the purpose for which it is being raised.
  • the KIC feeding method of this invention is particulaly suitable for use in raising "broilers", which are hen chickens usually marketed around 10 weeks of age. It is also applicable to the raising of capons.
  • the feeding method of this invention may reduce the cholesterol content of the meat in the finished chickens. This cholesterol reducing effect becomes more pronounced as the protein content of the diet is increased, being especially marked with diets containing more protein than normally required for the growth stage of the chickens.
  • the chicken feed compositions will usually be composed of mixtures of feed ingredients, including protein-providing ingredients.
  • the feed compositions may comprise complete feeds or feed concentrates.
  • the feeds preferably should contain at least a normally adequate amount of protein for the age ot the chickens. Diets essentially deficient in protein should be avoided.
  • Starter feeds containing at least 22% protein by weight (feed dry basis) are preferred for 0 to 4 weeks of age. Finishing rations used from 5 weeks on may contain a lesser amount of protein, but preferably contain at least 18% protein.
  • the amount of leucine in the diet of the chickens is preferred to not over 12% by weight based on the dry weight of the total protein being consumed, and preferably less than 10% by weight.
  • the method of this invention as applied to young chickens comprises orally administering at least 0.01 and preferably at least 0.05 weight percent (wt %) of alphaketoisocaproate (KIC), based on the dry weight of the total diet.
  • KIC alphaketoisocaproate
  • the amount of KIC is referenced to sodium KIC and its molar equivalents.
  • the amount of KIC administered to the chickens is from 0.05 to 0.1 up to 0.5 wt % KIC (sodium KIC basis) based on the dry weight of the feed consumed by the chickens. Higher levels of KIC, such as in the range from 0.5 to 1%, could be used but have not been found to provide any added benefit.
  • the amount of KIC may be specified in relation to the feed composition.
  • admixed feed compositions may contain from 0.05 to 1.0 wt % KIC (sodium KIC basis) in relation to the dry weight of the feed composition.
  • the feed compositions preferably contain from 0.1 to 0.5 wt % KIC (sodium KIC basis) of the feed dry weight.
  • the feed compositions also preferably contain at least an adequate amount of protein.
  • Illustrative feed compositions for use in practicing the present invention witn young chickens are set out below.
  • the compositions are specially designed for use with chickens being raised for broiler production.
  • Ration A is designed for use from 0 to 4 weeks of age, and Ration B from 4 to 6 or 4 to 8 weeks of age.
  • NaKIC or CaKIC is added to these rations in amounts on a dry matter basis equal to 0.1 to 0.2 wt. %.
  • the method of this invention can have beneficial effects on both the quantity and quality of the eggs laid.
  • the number of eggs laid can be increased.
  • the cholesterol content of the egg yolks can be reduced. Both of these advantages can be important in connection with commercial egg production.
  • KIC powders can be mixed with dry feeds for dry feed compositions or the water-soluble KIC salts can be administered by dissolving in drinking water.
  • Sodium KIC is preferred, and it is preferred to mix the dry KIC salt with the dry chicken feed ingredients at predetermined concentrations.
  • the KIC salt can be incorporated by using standard mixing and blending equipment. KIC is probably substantially uniformly distributed throughout the feed. After mixing, if desired, the feed material may be further processed, such as by conversion to pellets.
  • complete feed compositions or diets for the laying chickens preferably contain not over 12% leucine based on the total protein being consumed, and less than 10% by weight leucine is believed to be optimum.
  • the amount of KIC to be administered to the laying chickens is in general from 0.01 to 1.0 weight percent (wt %) of KIC based on the dry weight of the total feed diet. This amount of KIC is referenced to sodium KIC and its molar equivalents.
  • the amount of KIC administered to the laying chickens is from 0.05 to 0.5 wt % KIC (sodium KIC basis) on the dry weight of the feed consumed by the chickens, such as 0.1 to 0.2% NaKIC.
  • the amount of KIC may be specified in relation to the feed composition.
  • admixed feed compositions may contain from 0.01 to 1.0 wt % KIC (sodium KIC basis) in relation to the dry weight of the feed composition.
  • the feed compositions preferably contain from 0.05 to 0.5 wt %.
  • KIC sodium KIC
  • Such feed compositions will usually contain at least 10% protein and may contain up to 18% protein (N x 6.25).
  • Cattle which may be beef cattle or dairy cattle, can be fed KIC as an additive to their feed for several days prior to shipment, such as preferably at least 5 to 10 days, if the cattle have not been regularly receiving KIC-containing feeds.
  • the amount of KIC administered can be increased over that used for regular feeding.
  • rumen-protected KIC sodium KIC basis
  • rumen-protection of the KIC is desirable, as previously described. If sodium KIC is used in unprotected form, the amount orally administered may be increased up to 20 to 500 mg KIC (NaKIC basis) per kilogram of body weight per 24 hours.
  • the KIC may be parenterally administered, such as by intramuscular injection. Unprotected KIC can be used. It will probably be preferable to administer two or more injections on successive days prior to shipment.
  • the injections may be prepared in a sterile aqueous solution of sodium KIC, and may contain from 50 to 4000 milligrams of sodium KIC per dose.
  • KIC KIC
  • administration of KIC may be continued by oral feeding. It is believed that this will also be of value in reducing the adverse effects of shipping stress.
  • the amount of rumen-protected KIC to be used in the feeds for post-shipment administration can range from .50 to 50 milligrams KIC (sodium KIC basis) per kilogram of body weight.
  • the method, feed composition, and results obtainable by the present invention are further illustrated by the following experimental examples.
  • the lambs used in Trial 1 consisted of medium-frame crossbred wethers and ewes weighing 26 to 31 kg.
  • the lambs used in Trial 2 consisted of medium-framced crossbred rams weighing 18 to 25 kg. Each animal was raised as a single. The lambs were housed in a temperature controlled room in individual pens with nipple waterers. When received, the lambs were vaccinated for enterotoxemia. They were allowed to adjust to the pens and the environment for 10 days. One day before the trial began, the lambs were sheared and placed on their respective dietary treatments. The lambs were allotted blocking by weight and sex into two dietary treatment groups. Growth and feed consumption were measured bi-weekly.
  • the SMB (soybean meal-containing) and the CGM (corngluten-containing) diets were fed twice per day in quantities ensuring that feed was before the lambs at all times.
  • the diets were calculated to be equivalent to each other with respect to metabolizable protein, ether extract, fiber, and minerals with the exception of calcium and phosphorus.
  • the CGM diet contained less calcium (0.68 v. 0.74%) and phosphorus (0.30 v. 0.47%), and had a higher calcium to phosphorus ratio (2.29 v. 1.57) than the SMB diet.
  • the CGM diet was calculated to contain slightly more energy (TDN 81.7 vs. 79.0, NEm 1.88 v. 1.86, Neg.
  • the CGM diet contained slightly more crude protein on a dry matter basis than did the SBM diet (20.5 v. 19.8%).
  • the soybean meal ingredient contained about 3.5 wt % leucine, while the corn gluten meal ingredient contained about 15 wt % leucine.
  • the CGM diet was therefore higher in leucine than the SBM diet, containing an estimated 16 wt % leucine as compared with an estimated 8 wt % leucine based on total crude protein in the diet.
  • Cows were fed ad libitum a total mixed ration twice daily (7:30 a.m. and 5:30 p.m.) with feed refusals collected before the morning feeding.
  • the diet consisted of 31% chopped alfalfa hay, 18% corn silage, and 41% grain mix (as a % of the dry matter).
  • the grain mix was calculated to contain 1.55 Meal NE/kg dry matter and 16% crude protein.
  • a major portion of the grain protein was from expeller processed soybean meal with higher than usual bypass characteristics.
  • the cows were consuming protein in excess of their normal requirements.
  • the grain ration contained an estimated 10% leucine (total protein basis), and the complete diet contained an estimated 9% leucine (total protein basis).
  • KIC was fed in a mixture which consisted of Na-KIC, corn gluten meal, hvdrogenated soy oil and paraffin in a ratio of 2:1.0:0.1:0.1. The mixture was extruded and formed into crumbles. At least part of the KIC may have escaped rumen degradation with this treatment. Additionally, 100 units of tocopherol were added per gram of Na-KIC to prevent oxidation of KIC. Control animals were fed an equivalent amount of the same mixture but without KIC added.
  • control period designated weeks -2 and -1
  • all cows received the same diet.
  • the trial period extended over the next three weeks (weeks 1, 2, 3) during which cows received either the KIC or control mix top-dressed on their diets twice per day (half the dose in the morning, half in the evening).
  • daily milk yield, milk composition, and feed consumption was measured for each cow.
  • urinary catheters were inserted and total urine and fecal collections were made for 48 hrs. Results of production and nitrogen balance studies were analyzed statistically using each cow as her own control. The trial effect was measured by subtracting the average control period value from the value during the treatment period. ANOVA was used to detect differences between the KIC-fed and control groups.
  • Laying hens (69 weeks of age) were randomly assigned to either a control diet or a diet containing 0.2 wt % KIC (Na). For the next 28 days feed consumption was recorded and eggs collected. Eggs were weighed and analyzed for egg yolk cholesterol. The feed composition is shown in Table C and the results in Table D. The total protein was about 18% on a dry matter basis, and the amount of leucine was about 9% of the protein. The control diet was the same except for the omission of the KIC.
  • Soyabean meal (48% protein) 214.0
  • Meat & bone meal (50% protein) 20.0
  • experiment 3 72 castrated male cattle were allotted to 12 pens of 6 animals each. Three pens were assigned to each treatment: 0.0% KIC, 0.02% KIC, 0.07% KIC, and 0.20% KIC. Animals were fed ad libitum the respective diets for 6 weeks. At the end of the 6-week periods, 100-ml blood samples were collected from each animal, and lymphocyte and neutrophil function were evaluated.
  • Sheep in experiments 1 and 2 were fed diets based on a mixture of 48% corn, 5% molasses, 20% alfalfa meal, 0.8% limestone, 0.6% salt-mineral-vitamin mix and ⁇ 25% of a protein supplement (either soybean meal, corn gluten meal, or corn gluten feed).
  • the diets were isonitrogenous and analyzed to be -20% crude protein and 89% dry matter.
  • the KIC diet consisted of the basal diet to which was added 1% calcium-KIC, whereas the control diet was the basal diet plus 0.25% calcium carbonate.
  • the basal cattle diet (experiment 3) consisted of 49% corn, 24% corn-cobs, 18% soybean meal, 7% molasses, 1.3% limestone, 0.25% dicalcium phosphate, 0.23% salt, 0.02% tracemineral premix, and 0.11% vitamin premix.
  • the basal diet was supplemented with w/w 0.05% control pellets, 0.04% KIC pellets or 0.4% KIC pellets. All animals consumed ⁇ 10 kg of feed per day, resulting in ⁇ 0, 2, 7, or 20 g of Ca-KIC consumed per animal per day or 0, .02, .07, and .2% KIC of the total diet.
  • KIC pellets were made by mixing zein, ethanol, KIC, limestone, bentonite, and water in a ratio of 8.3:7.4:5.2:3: 2.1. This mixture was extruded through a die of 15 mm directly into a vat of liquid nitrogen. The shattered pellets were spread out and allowed to air-dry for 2 days. The pellets were coated with zein (2% w/w) bv spraying with a 30% zein solution made in 80% ethanol. The pellets again were air-dryed. Control pellets were made similarly to the KIC pellets except that the mixture was zein, limestone, ethanol, bentonite, and water in a ratio of 12:12:7.5:2.7:1. When KIC pellets were placed in the rumen (nylon bag technique), 33% of the KIC added was present in the bags after 24 hr of rumen fermentation. It was estimated that uncoated KIC was 95% degraded in the rumen.
  • lymphocyte blastogenesis Blood was collected by jugular venapuncture into acid-citrate-dextrose anticoagulant. Lymphocytes and neutrophils were isolated, and lymphocyte blastogenesis and neutrophil function evaluated. KIC was obtained from SOBAC, Paris, France. Zein was purchased from Freeman Industries, Tuckahoe, NY. Each experiment was statistically analyzed by analysis of variance. In sheep experiments, individual animals were the experimental units, whereas pen means were analyzed in the cattle experiment. The changes in lymphocyte blastogenesis are summarized in Table F. In all three experiments, average background blastogenesis was increased in KIC-treated groups.
  • KIC phytohemagglutinin
  • ConA Concanavalin A
  • PWM pokeweek mitogen
  • KIC did not alter neutrophil random migration, Staphylococcus aureus ingestion, cytochrome C reduction, iodination, or antibody-dependent cell-mediated cytotoxicity in any experiment, indicating that KIC does not alter neutrophil function. Feed intake in control and KIC-treated animals was not different in any experiment.
  • experiment 1 sixteen female pigs weighing 20-30 kg were used. Seven days before study, catheters were surgically placed in the right atria for blood sampling. Animals were housed in individual cages during the recovery period and had free access to water. Preceding the experiment, animals were fed twice daily a basal diet (2% of body weight per feeding). The basal diet consisted of a corn-soybean mix, adequate in all minerals and vitamins and containing approximately 14% crude protein. Test meals were formulated by additions to a basal diet.
  • Cortisol was measured by coated tube kits (Gammacoat, Travenol-Genetech Diagnostics, Cambridge, MA). Leucine and KIC were measured by high pressure liquid chromatography. Crystalline leucine was obtained from Sigma Chemical (St. Louis, MO) and KlC-sodium was obtained from . OBAC (Paris, France). Statistical analysis of the individual pig responses was conducted on mean plasma concentrations before the meal (-20 to 0 min) and after the meal (120 to 240 min). When the overall treatment F-value was significant, differences between individual treatments were determined using the pooled SEM and a T-test.
  • Table G presents the changes in plasma leucine, KIC and cortisol concentration in pigs before and after ingestion of control, leucine and KIC meals.
  • Ingestion of the control meal resulted in a small significant increase in leucine concentration while plasma KIC concentration remained constant.
  • Ingestion of the leucine meal caused plasma leucine concentration to increase 4 fold whereas KIC ingestion caused a doubling of leucine concentration.
  • Plasma KIC concentration increased from a basal concentration of ⁇ 40 ⁇ M to 90 ⁇ M and over 100 ⁇ M in pigs fed KIC- and leucine-supplemented meals, respectively.
  • Plasma cortisol concentration did not change after the control meal (Table G).
  • the addition of leucine to the diet resulted in a small decrease in plasma cortisol (-14%, nonsignificant).
  • Addition of KIC to the diet, however, resulted in a 40% decrease in cortisol concentration by 240-300 minutes after the meal (p ⁇ .01).
  • the treatments consisted of four levels of Ca-KIC in a pelleted supplement: 0%, 0.02%, 0.07%, and 0.20% of the basal diet (0.05% control pellets, 0.04% KIC pellets, 0.14% KIC pellets, and 0.40% KIC pellets).
  • the pellets were preweighted and top-dressed on the basal diet twice daily.
  • the cattle on the 0.20% KIC were removed from the experiment.
  • the cattle were not implanted with a growth promotant nor were ionophores included in the diet.
  • the cattle were placed in the feedlot and fed a growing ration for 5 weeks prior to the start of the experiment.
  • the cattle were weighed on 2 consecutive days at the beginning and end of the experiment, and every 14 days during the trial.
  • the cattle were sold through a commercial beef processing plant when they were appraised by visual examination to grade Choice. Loin eye area and fat thickness over the loin were measured on each carcass. Quality and yield grades, and percent kidney, heart, and lepvic (KHP) fat were estimated by the federal graders.
  • KIC pellets resistant to rumen degradation, were made by mixing zein, ethanol, KIC, limestone, bentonite and water in a ratio of 8.3:7.4:5.2: 3:2:1. This mixture was extruded through a die of 15 mm directly into a vat of liquid nitrogen. The shattered pellets were spread out and allowed to air-dry for two days. The dried pellets were coated with zein (2% w/w) by spraying with a 30% zein solution made in 80% ethanol. The pellets again were air-dried.
  • Control pellets were made similar to the KIC pellets except that the mixture was zein, limestone, ethanol, bentonite and water in a ratio of 12:12:7.5:2.7:1.
  • KIC pellets were placed in the rumen (nylon bag technique), 45% of the KIC added was present in the bags after 36 hr of rumen digestion.
  • KIC was obtained from SOBAC, Paris, France. Zein was purchased from Freeman Industries, Tuckahoe, N.Y. Each experiment was statistically analyzed by analysis of variance with three pens per treatment.
  • KIC may have significant potential as a feed additive for growing feedlot cattle.

Abstract

Le rendement commercial d'animaux domestiques peut être amélioré par administration de céto-isocaproate sous une forme nutritionnellement utilisable par l'animal. Le céto-isocaproate améliore la blastogénèse des lymphocytes T de l'animal et réduit les niveaux de cortisole plasmatique. Il en résulte un effet favorable sur la fonction immunitaire de l'animal, effet qui peut être utilisé pour combattre la suppression des réactions immunitaires due à un état de stress. Ledit procédé peut s'appliquer à l'élevage bovin, à l'élevage laitier, à l'élevage ovin, à l'élevage porcin et à l'élevage de volailles, servant respectivement à produire de la viande, du lait, de la laine et des oeufs. Les avantages pratiques peuvent également comprendre une amélioration de la production et une diminution du taux de cholestérol de la viande et des oeufs et une augmentation de rendement dans la production de lait, de laine et d'oeufs.The commercial yield of domestic animals can be improved by administration of keto-isocaproate in a form nutritionally usable by the animal. Keto-isocaproate improves the blastogenesis of animal T cells and reduces plasma cortisole levels. This results in a favorable effect on the immune function of the animal, an effect which can be used to combat the suppression of immune reactions due to a state of stress. Said method can be applied to cattle farming, dairy farming, sheep farming, pig farming and poultry farming, used respectively to produce meat, milk, wool and eggs. Practical benefits may also include improved production and lower cholesterol levels in meat and eggs and increased yield in the production of milk, wool and eggs.

Description

IMMUNOMODULATOR FOR IMPROVING COMMERCIAL PERFORMANCE OF DOMESTIC ANIMALS
FIELD OF INVENTION
The field of this invention is methods for improving the commercial performance of domestic animals. The invention is particularly concerned with the administration of alphaketoisocaproate (KIC) to domestic animals for improving the immune and/or metabolic functions of the animals.
RELATED APPLICATIONS
This application is a continuation-in-part of copending application Serial Nos. 838,357, 838,356, and 838,355, all filed March 11, 1986.
BACKGROUND OF INVENTION
Keto analogs of essential amino acids have been proposed for use in human nutrition as partial or complete substitutes for the corresponding amino acids, including, for example, leucine, isoleucine, methionine, phenylalanine, and valine. Originally, the use of such keto analogs was proposed by Dr. MacKenzie Walser as supplementation to protein-reduced diets in uremia. See, for example, Walser, et al., J. Clin. Inv. (1973) 52:678-690. Further experiments by Walser and associates demonstrated a nitrogen sparing effect from mixtures of branched-chain keto acids. Saiper and Walser, Metabolism (1977) 26:301-308. Patents have issued to Walser on the use of keto analogs of essential amino acids for promotion of protein synthesis and suppression of urea formation in humans. (U.S. patents 4,100,161 and 4,101,293). A recent review summarized existing knowledge with respect to the administration of branched-chain keto acids to humans. "New Aspects of Clinical Nutrition", pp. 319-324 (Karger, Basel, 1983).
The keto acid analog of L-leucine is alpha-ketoisocaproate (KIC) which is also sometimes referred to as "ketoleucine". KIC does not have L and D forms as does leucine. It is known that there is an interconversion of KIC and leucine in tissues. Published studies have demonstrated that KIC can be substituted in animal diets for leucine providing that larger molar amounts of KIC are used.
Chawla, et al. reported that weight loss by rats being fed a diet deficient in leucine could be prevented by adding equimolar amounts of KIC to the diet. J. Nutr. (1975) 105: 798-803. Other studies in rats have demonstrated that KIC is utilized less efficiently than leucine. Boebel et al. reported that the efficiency of KIC was only about 56% with reference to leucine. Boebel and Baker, J. Nutr. (1982) 112: 1929-1939. Chow et al. obtained similar results, reporting that substitution of KIC for leucine reduced feed efficiency by approximately 33%. Chow and Walser, J. Nutr. (1974) 104: 1208-1214.
Walser and associates have published a study of the oral dosing of KIC to rats in which an increased efficiency of utilization of nitrogen and minerals was apparently observed. Abras and Walser, Am. J. Clin. Nutr. (1982) 36:154161. Prior to the present invention, there are no known reports describing the feeding of KIC to domestic animals.
KIC has not been heretofore known as an immunomodulator in humans or animals, nor has it been suggested that KIC can be used to reduce plasma cortisol (hydrocortisone), or that it can be used to favorably alter immune function by enhancing blastogenesis of T lymphocytes.
It is known that in cattle stress-induced immunosuppresion is accompanied by increased plasma cortisol concentrations. Roth, Chap. 13, pages 225-243, in "Animal Stress" (published by Amer. Physiol. Soc, 1985). Such stress-induced immunosuppression can occur in other domestic animals. It can result from a wide variety of stresses, such as handling, shipping, injury, etc. However, this problem is particularly acute with cattle. Bovine respiratory disease complex, commonly known as "shipping fever", is recognized as a stressassociated condition. See Roth, above cited, pages 226-227. Considerable research has been devoted to finding ways of combating cattle shipping fever. See, for example, Kaeberle, et al., Immunopharmacology (1984), 8:129-136; and Roth, et al., Immunopharmacology (1984), 8:121-128.
It is known that T lymphocytes have important functions in immunological defense against microorganisms. See, for example, Williams et al., "Hematology", Chap. 102, pages 927-928 (2nd Ed., 1977, McGraw-Hill). In their immune function, T lymphocytes, which are normally quiescent, undergo mitosis with accelerated DNA production. Williams, et al., above cited, pages 882-884. This process of T lymphocyte activation is known as blastogenesis. The degree of blastogenesis activation of T lymphocytes can be determined in vitro using mitogens. The most commonly employed mitogens for this purpose are phytohemagglutin (PHA), pokeweed mitogen (PWM), and concanavalin A (conA). Williams et al., citedabove, pages 895, and 923.
The present invention provides a novel method and novel feed compositions for improving the commercial performance of domestic animals. The method utilizes alpha-ketoisocaproate (KIC) as an immunomodulator for improving immune function, and/or as a nutrient additive for improving metabolic function. It has been discovered that the administration of KIC favorably alters immune function, as evidenced by enhanced blastogenesis of the T lymphocytes. A further effect on immune function is the marked reduction of plasma cortisol. The enhancement of lymphocyte blastogenesis is of value in increasing disease resistance. Reduced plasma cortisol is expected to be ameliorating in counteracting stress associated immunodepression in domestic animals, and should be useful for controlling cattle shipping fever.
It is not known to what extent the .beneficial effects on immune function are related to the beneficial effects on metabolic function. However, it has been found that both immune and metabolic functions can be improved concurrently by feeding KIC-containing feeds. Thus, in the case of animals being raised for meat production, such as young cattle and sheep, young chickens, and veal calves, KIC can be used as a "growth promotant immunomodulator"--an unprecedented kind of feed additive.
Improved metabolic function can also be obtained with mature animals, including dairy cattle, wool-producing sheep, and laying chickens. The production of milk, wool, and eggs can be improved, while at the same time increasing the disease resistance of the animals. With nursing domestic mammals, such as cattle, sheep, and hogs, the improvement in the quality and quantity of the milk benefits the offspring. A further benefit is that the nursing mother mammals are more disease resistant.
The administration of KIC to cattle prior to shipment is expected to mitigate the stress-related effects of shipping fever. By administering the KIC in feed for several days prior to shipment, and then continuing the KIC feeding after shipment, it should be possible to at least partially offset the weight loss associated with shipping stress.
For the purposes of the present invention, the KIC should be in a nutritionally-utilizable form. For incorporation in feeds, the KIC should be absorbable in the digestive system, while for parenteral administration a water-soluble form is preferred. For example, it may be used in its free acid form, but its sodium, potassium, ammonium, or calcium salts are preferred. Ammonium and alkali metal salts are more water-soluble, while alkaline earth metal salts such as calcium salt are less water-soluble. These differences in solubility do not appear significant in feeding ruminants such as cattle and sheep. For ruminants, it has been found that the calcium salt is generally comparably effective with the sodium salt, and may have some advantage by dissolving more slowly in rumen fluid. For non-ruminant mammals and poultry sodium KIC is preferred, but other less soluble salts can be used by increasing the amount administered.
Alpha-ketoisocaproate (KIC) is available commercial ly or can be synthesized by known procedures. KIC in the form of its sodium or calcium salts can be purchased from SOBAC, 335 Rue Saint Honore, Paris, France, and/or through Sigma Chemical Company, St. Louis, Missouri.
Sodium and calcium salts of KIC as supplied commercially are substantially pure compounds and are in the form of dry powders. However, high purity is not necessarily required for the purposes of the present invention.
KIC powders can be mixed with dry feeds, or for non-ruminant mammals and poultry water-soluble KIC salts can be administered by dissolving in drinking water. For parenteral administration, such as intramuscular injection, sodium KIC can be dissolved in a sterile water. For feed use to assure administration at a desired level, it is preferred to mix the dry KIC salt with the dry feed ingredients at a predetermined concentration. The KIC salt can be incorporated by dry blending using standard mixing equipment. The KIC should be substantially uniformly distributed throughout the feed. After mixing, if desired, the feed material may be further processed, such as by conversion to pellets.
Most feed compositions are composed of mixtures of feed ingredients. Such mixed feed compositions may comprise complete feeds or feed concentrates. It has been found preferable in promoting metabolic function with KIC to use only limited quantities of proteinaceous feed ingredients which are high in leucine content. Such feed ingredients include blood meals, which may contain 16 to 20% leucine, and corn gluten meal containing 18 to 20% leucine (based on the protein dry weight). In contrast, soybean meal contains only about 8 to 9% leucine, and can therefore be used as a carrier for KIC in the form of a protein supplement.
For the metabolic improvement purpose of the present invention, it is believed desirable to limit the amount of leucine in the diet to not over 12% of the dry weight of the total protein being consumed by the animal. The amount of protein can be calculated by determining nitrogen and multi plying by a standard conversion factor of 6.25 (viz. N x (6.25). In preferred embodiments, the amount of leucine is limited to less than 10% by weight of total protein. Consequently, in the formulation of complete feeds or feed concentrates which are to provide a major portion of the animal's diet, it is preferred to maintain the leucine content of the feed composition to not over 12% and preferably less than 10% (based on total protein). The immune function improvement of KIC, however, can still be obtained at higher leucine levels.
Broadly stated, the method of this invention can comprise orally administering from as low as 0.5 to 2 milligrams (mg) up to as much as 500 to 1000 mg of alpha-ketoisocaproate (KIC) per kilogram of body weight per 24 hours (hrs). (The amounts of KIC are referenced to sodium KIC or molar equivalents of other KIC compounds.) In certain preferred embodiments, the amount of KIC administered to the animals can range from 1 to 100 mg (Na KIC basis ) per kg body weight per 24 hrs. For purposes of the present application, the amounts of KIC should be understood to relate to the sodium salt of KIC as the weight basis, or to a molar equivalent amount of the calcium salt or other salts or derivatives, which are nutritionably absorbable and utilizable.
When KIC is combined with the feed material as a uniform admixture, and the feed composition provides the major protein source for the diet, the amount of KIC may be specified in relation to the feed composition. For example, the admixed feed composition may contain from as low as 0.01 to 0.1 up to 1.5 to 2.0 wt % KIC (Na KIC dry feed weight basis). Such feed compositions will usually contain at least 10% protein and may contain up to 24% protein N x 6.25).
While the method of this invention is generally applicable to domestic animals, for optimum results it is desirable to adapt the amounts of KIC administered in the feed compositions for the particular animal species, and to the purpose for which they are being raised.
In feeding KIC to ruminants, protection of the KIC against rumen destruction is desirable. The following sections will discuss specific applications of the invention and preferred procedures. However, it should be understood that the invention is generally applicable to domestic animals, and that the general information set out above is applicable.
Ruminants
In the feeding of cattle, including beef cattle, dairy cattle, growing sheep raised for meat production, and mature sheep for wool production, it would be necessary to employ much larger amounts of KIC since it is subject to rumen destruction. Tests indicate that as much as 90-95% of the KIC may be lost. It is therefore very desirable to protect the KIC against rumen destruction. For example, KIC tablets may be coated with animal blood or with corn protein (zein). A specific protection procedure using zein is described in Example VI. Other proteins can be employed as coating materials which are resistant to rumen breakdown. Polymer coating may also be used such as those known to protect protein against rumen destruction. (See the rumen-protective coatings described in the U.S. Patents 4,181,708, 4,181,709, and 4,181,710). The coating employed should be one which is resistant to the mildly acid environment of the rumen while dissolving in the more acid environment of the abomasum. The amount of KIC required can be monitored by increasing the dosage until an appreciable reduction in plasma cortisol is observed.
When the KIC is fed to ruminants in rumen-protected form, a useful range is from 1 to 100 mg KIC per kg body weight per 24 hrs (Na KIC basis). In a substantially fully protected form, the amount administered can be from 2 to 50 mg KIC per kg body weight per 24 hours (NaKIC basis). Feed compositions containing such rumen-protected KIC and comprising substantially the entire diet of the ruminants may contain 0.1 to 0.5% KIC (NaKIC and feed dry weight basis). If unprotected KIC is used these amounts should be increased by a factor of 9 to 10. KlC-feeding is especially useful in the feeding of female and castrated and intact male cattle and sheep, but it can also be used with male ruminants if raised for meat production. Other uses include breeding stock and replacements. The method is preferably used with steers and heifers for beef production, and with wethers, rams, and ewes for lamb meat production and/or wool production. When the method is applied to sheep, improvements in meat production in relation to protein intake and/or increased wool production can be obtained. With mature sheep which are primarily being raised for wool production, the benefit of increased wool production in relation to protein intake is especially valuable. For meat production, with either beef cattle or sheep, an additional advantage can be reducing the cholesterol content of lean meat, and also probably improving carcass quality or grade. For all ruminants improvement in T lymphocyte function is obtainable.
Veal Calves
This invention is also usable with calves being raised for veal production. Technically such veal calves are not ruminants. They are suckling calves which remain monogastric, i.e., they do not develop a rumen, being fed milk or a milk substitute which provides a balanced diet for the veal calves. KIC fed to veal calves is therefore not subject to rumen loss.
From 1 to 100 mg KIC (NaKIC basis), per kg body weight per 24 hrs. can be used. Preferred KIC amounts are 2 to 50 mg (NaKIC basis) per kg body weight per 24 hrs. On a feed basis, a liquid milk replacer for veal calves may contain from 0.01 to 0.5% (NAKIC basis) KIC based on the dry matter content of the milk replacer, and preferably from 0.01 to 0.5% KIC on the same basis. Sodium KIC is preferred because of its water solubility. The limitations on leucine in the diets for the veal calves are preferably observed, as previously described. Lactating Domestic Mammals
The method and feed compositions of this invention are applicable to dairy cattle being managed for commercial milk production, and the method and feed compositions can also be advantageously used with lactating goats fed for commercial milk production. In addition, the invention provides a means for improving the milk produced by nursing mammals, including cattle, sheep, goats, horses, and swine. The young mammals being nursed thereby obtain the benefits of greater milk production and increased butterfat content. All of the foregoing instructions about the form and amount of KIC are applicable. However, it will be understood that the feeds employed can be adapted for the particular animal and the purpose for which it is being raised.
The following diets are illustrative of those for use with lactating animals when employing unprotected KIC.
DIET A
Complete Dairy Cattle Ration
Feed each cow
12 lbs early bloom alfalfa hay (17.5% crude protein, dry matter basis)
40 lbs corn silage
+4.3 lbs grain mix for each 10 lb milk
(3.5% fat) produced in excess of 25 lb. milk)
For grain mix, blend together: lbs. ton
51% coarse ground yellow corn 1020
13% coarse ground oats 260
30% solvent-soybean meal (44%) 600
3% cane molasses 60
0.5% dicalcium phosphate 10
0.5% calcium carbonate 10
0.5% salt 10
1.3% trace mineral-vitamin mix 6
1.2% Ca-KIC (unprotected) 24
2000 DIET B
Feed Concentrate for Lactating Sheep or Goats
To be used with sheep or goats being fed a 14% C.P. (d.m. basis) alfalfa-grass mixed hay ad lib. Feed 2.3 lbs concentrate per day to sheep weighing 130 lbs and nursing twins. Animals fed 2.3 lbs will consume 20 g Ca-KIC per day. This is about 0.8% of the total ration dry matter intake.
For concentrate, mix together and pellet: pounds/ton
89.5% ground yellow corn 1790
6.5% solvent-soybean meal (44%) 130 0.9% dicalcium phosphate 18 0.3% calcium carbonate 6
.5% salt 10
.3% Trace mineral-vitamin mix 6 2.0% Ca-KIC (unprotected) 40
DIET C
Lactating Swine Ration*
Mix: pounds/ton
84% Ground yellow corn 1680
13% solvent-extracted soybean meal (48.5%) 260 0.8% calcium carbonate 16 1.1% dicalcium phosphate 22 0.5% iodized salt 10 0.5% trace mineral-vitamin mix 10 0.1% Na-KIC (unprotected) 2
*15.6% CP, d.m. basis
Broiler Chickens
The KIC feeding method of this invention is particulaly suitable for use in raising "broilers", which are hen chickens usually marketed around 10 weeks of age. It is also applicable to the raising of capons. In addition to improving the rate of weight gain, the feeding method of this invention may reduce the cholesterol content of the meat in the finished chickens. This cholesterol reducing effect becomes more pronounced as the protein content of the diet is increased, being especially marked with diets containing more protein than normally required for the growth stage of the chickens.
The chicken feed compositions will usually be composed of mixtures of feed ingredients, including protein-providing ingredients. The feed compositions may comprise complete feeds or feed concentrates. The feeds preferably should contain at least a normally adequate amount of protein for the age ot the chickens. Diets essentially deficient in protein should be avoided. Starter feeds containing at least 22% protein by weight (feed dry basis) are preferred for 0 to 4 weeks of age. Finishing rations used from 5 weeks on may contain a lesser amount of protein, but preferably contain at least 18% protein. For optimized results, it is also believed desirable to include only limited quantities of proteinaceous feed ingredients which are high in leucine content.
For the purpose of the present invention, it is preferred to limit the amount of leucine in the diet of the chickens to not over 12% by weight based on the dry weight of the total protein being consumed, and preferably less than 10% by weight.
The method of this invention as applied to young chickens comprises orally administering at least 0.01 and preferably at least 0.05 weight percent (wt %) of alphaketoisocaproate (KIC), based on the dry weight of the total diet. (The amount of KIC is referenced to sodium KIC and its molar equivalents.) In preferred embodiments, the amount of KIC administered to the chickens is from 0.05 to 0.1 up to 0.5 wt % KIC (sodium KIC basis) based on the dry weight of the feed consumed by the chickens. Higher levels of KIC, such as in the range from 0.5 to 1%, could be used but have not been found to provide any added benefit. When KIC is combined with the feed material as a uniform admixture, and the feed composition is intended to provide substantially the complete diet of the chickens , the amount of KIC may be specified in relation to the feed composition. For example, admixed feed compositions may contain from 0.05 to 1.0 wt % KIC (sodium KIC basis) in relation to the dry weight of the feed composition. In preferred embodiments for the formulation of complete feeds, the feed compositions preferably contain from 0.1 to 0.5 wt % KIC (sodium KIC basis) of the feed dry weight. The feed compositions also preferably contain at least an adequate amount of protein.
Illustrative feed compositions for use in practicing the present invention witn young chickens are set out below. The compositions are specially designed for use with chickens being raised for broiler production. Ration A is designed for use from 0 to 4 weeks of age, and Ration B from 4 to 6 or 4 to 8 weeks of age. NaKIC or CaKIC is added to these rations in amounts on a dry matter basis equal to 0.1 to 0.2 wt. %.
RATION A
(23% protein)
Ingredients Weight (lbs)
Ground Corn 282 . 25
Soybean Meal 184 . 25
Calcium Carbonate 6 . 25
Dicalcium Phosphate 8 . 50
Fat(1) 6 .25
MHA 1 . 07
Premix (2) 11 . 43
TOTAL lbs. 500.00
(1) Methionine hydroxy analogue.
(2) Set out below. RATION B
(18% Protein)
Ingredients Weight (lbs)
Ground Corn 350.75 Soybean Meal 119.50 Calcium Carbonate 9.75 Dicalcium Phosphate 7.50 Premix(1) 11.43 Solulac(2) 1.07
Total lbs. 500.00
( 1 ) Set out below. ( 2 )
Premix Composition
Vitamin A-30 234 grams
Vitamin D3-40 54 grams
Vitamin K-16 63 grams
Vitamin E-125 36 grams
Riboflavin 135 grams
Niacin 63 grams
Calcium Panothanate 27 grams
Choline 1.33 lb.
Vitamin B12 76 .5 grams
Folic Acid 4.5 grams
Nutrigard 1 .0 lb.
Methionine Analogue 180 grams
Trace Minerals 270 grams
Salt 5 lbs.
Carrier 35 .5 lbs.
Laying Chickens
As applied to laying chickens, the method of this invention can have beneficial effects on both the quantity and quality of the eggs laid. The number of eggs laid can be increased. In addition it has been found that the cholesterol content of the egg yolks can be reduced. Both of these advantages can be important in connection with commercial egg production.
KIC powders can be mixed with dry feeds for dry feed compositions or the water-soluble KIC salts can be administered by dissolving in drinking water. Sodium KIC is preferred, and it is preferred to mix the dry KIC salt with the dry chicken feed ingredients at predetermined concentrations. The KIC salt can be incorporated by using standard mixing and blending equipment. KIC is probably substantially uniformly distributed throughout the feed. After mixing, if desired, the feed material may be further processed, such as by conversion to pellets.
As previously described, complete feed compositions or diets for the laying chickens preferably contain not over 12% leucine based on the total protein being consumed, and less than 10% by weight leucine is believed to be optimum. The amount of KIC to be administered to the laying chickens is in general from 0.01 to 1.0 weight percent (wt %) of KIC based on the dry weight of the total feed diet. This amount of KIC is referenced to sodium KIC and its molar equivalents. In preferred embodiments, the amount of KIC administered to the laying chickens is from 0.05 to 0.5 wt % KIC (sodium KIC basis) on the dry weight of the feed consumed by the chickens, such as 0.1 to 0.2% NaKIC.
When KIC is combined with the feed material as a uniform admixture, and the feed composition is intended to provide substantially the complete diet of the chickens, the amount of KIC may be specified in relation to the feed composition. For example, admixed feed compositions may contain from 0.01 to 1.0 wt % KIC (sodium KIC basis) in relation to the dry weight of the feed composition. In preferred embodiments for the formulation of complete feeds, the feed compositions preferably contain from 0.05 to 0.5 wt %. KIC (sodium KIC) based on feed dry weight. Such feed compositions will usually contain at least 10% protein and may contain up to 18% protein (N x 6.25). Cattle Shipping
When cattle are to be transported they thereby become subject to the bovine respiratory disease complex known as "shipping fever", and administration of KIC can be of value in counteracting the increased plasma cortisol that has been found to be associated with shipping stress. Cattle, which may be beef cattle or dairy cattle, can be fed KIC as an additive to their feed for several days prior to shipment, such as preferably at least 5 to 10 days, if the cattle have not been regularly receiving KIC-containing feeds. For the purpose of counteracting increased cortisol, the amount of KIC administered can be increased over that used for regular feeding. For example, it is believed that it would be desirable to orally administer at least 2 to 50 milligrams of rumen-protected KIC (sodium KIC basis) per kilogram of body weight per 24 hours and to continue the administration for at least five days prior to shipment. For maximum effect, rumen-protection of the KIC is desirable, as previously described. If sodium KIC is used in unprotected form, the amount orally administered may be increased up to 20 to 500 mg KIC (NaKIC basis) per kilogram of body weight per 24 hours.
Alternatively or additionally to oral administration of KIC for counteracting shipping fever, the KIC may be parenterally administered, such as by intramuscular injection. Unprotected KIC can be used. It will probably be preferable to administer two or more injections on successive days prior to shipment. The injections may be prepared in a sterile aqueous solution of sodium KIC, and may contain from 50 to 4000 milligrams of sodium KIC per dose.
For a period of several days after shipment, such as 5 to 10 days, administration of KIC may be continued by oral feeding. It is believed that this will also be of value in reducing the adverse effects of shipping stress. The amount of rumen-protected KIC to be used in the feeds for post-shipment administration can range from .50 to 50 milligrams KIC (sodium KIC basis) per kilogram of body weight. The method, feed composition, and results obtainable by the present invention are further illustrated by the following experimental examples.
EXPERIMENTAL EXAMPLES Lamb Trials
The lambs used in Trial 1 consisted of medium-frame crossbred wethers and ewes weighing 26 to 31 kg. The lambs used in Trial 2 consisted of medium-framced crossbred rams weighing 18 to 25 kg. Each animal was raised as a single. The lambs were housed in a temperature controlled room in individual pens with nipple waterers. When received, the lambs were vaccinated for enterotoxemia. They were allowed to adjust to the pens and the environment for 10 days. One day before the trial began, the lambs were sheared and placed on their respective dietary treatments. The lambs were allotted blocking by weight and sex into two dietary treatment groups. Growth and feed consumption were measured bi-weekly. All lamb weights were taken after a 12 to 16 hour fast. The animals were slaughtered at 50 kg in the Iowa State University Meat laboratory facilities at Ames, Iowa. At slaughter, the lamb's internal organs and wool were weighed and sampled, loin eye area and back fat measured, and carcasses separated into fat, lean, and bone.
The SMB (soybean meal-containing) and the CGM (corngluten-containing) diets (compositions given in Table A) were fed twice per day in quantities ensuring that feed was before the lambs at all times. The diets were calculated to be equivalent to each other with respect to metabolizable protein, ether extract, fiber, and minerals with the exception of calcium and phosphorus. The CGM diet contained less calcium (0.68 v. 0.74%) and phosphorus (0.30 v. 0.47%), and had a higher calcium to phosphorus ratio (2.29 v. 1.57) than the SMB diet. The CGM diet was calculated to contain slightly more energy (TDN 81.7 vs. 79.0, NEm 1.88 v. 1.86, Neg. 1.23 vs. 1.22). Chemical analysis indicated that the CGM diet contained slightly more crude protein on a dry matter basis than did the SBM diet (20.5 v. 19.8%). The soybean meal ingredient contained about 3.5 wt % leucine, while the corn gluten meal ingredient contained about 15 wt % leucine. The CGM diet was therefore higher in leucine than the SBM diet, containing an estimated 16 wt % leucine as compared with an estimated 8 wt % leucine based on total crude protein in the diet.
The results of Table B indicate that the KIC increased gain and feed efficiency in the SBM diets. The CGM diets did not perform as well when supplemented with KIC, but KIC increased wool growth in both SBM and CGM diets. Cortisol was significantly lower in all the KIC supplemented diets.
The results for Trial 2 are summarized below in Table C. The results of Table C show that KIC improved performance in the SBM diet but poorer performance was observed in the CGM diet. Wool growth was improved with KIC supplementation in both diets. Cortisol was significantly lower in the KIC supplemented sheep.
EXAMPLE II Dairy Cattle Trial
Eight Holstein and four Brown Swiss cows were assigned randomly (hlocking for lactation number and breed) to either a control or treatment group. Four of the Holsteins and two of the Brown Swiss were in their first lactation and all cows were between 134-283 days into lactation (midlactation). Cows were milked twice daily (2:30 a.m. and 2: 00 p.m.).
Cows were fed ad libitum a total mixed ration twice daily (7:30 a.m. and 5:30 p.m.) with feed refusals collected before the morning feeding. The diet consisted of 31% chopped alfalfa hay, 18% corn silage, and 41% grain mix (as a % of the dry matter). The grain mix was calculated to contain 1.55 Meal NE/kg dry matter and 16% crude protein. A major portion of the grain protein was from expeller processed soybean meal with higher than usual bypass characteristics. The cows were consuming protein in excess of their normal requirements. The grain ration contained an estimated 10% leucine (total protein basis), and the complete diet contained an estimated 9% leucine (total protein basis).
During the treatment period half the cows received Na-KIC at 0.75% of the diet dry matter. KIC was fed in a mixture which consisted of Na-KIC, corn gluten meal, hvdrogenated soy oil and paraffin in a ratio of 2:1.0:0.1:0.1. The mixture was extruded and formed into crumbles. At least part of the KIC may have escaped rumen degradation with this treatment. Additionally, 100 units of tocopherol were added per gram of Na-KIC to prevent oxidation of KIC. Control animals were fed an equivalent amount of the same mixture but without KIC added.
During the first two weeks of the experiment (control period; designated weeks -2 and -1), all cows received the same diet. The trial period extended over the next three weeks (weeks 1, 2, 3) during which cows received either the KIC or control mix top-dressed on their diets twice per day (half the dose in the morning, half in the evening). Throughout the experiment, daily milk yield, milk composition, and feed consumption was measured for each cow. At the end of the control period and at the end of the treatment period, urinary catheters were inserted and total urine and fecal collections were made for 48 hrs. Results of production and nitrogen balance studies were analyzed statistically using each cow as her own control. The trial effect was measured by subtracting the average control period value from the value during the treatment period. ANOVA was used to detect differences between the KIC-fed and control groups.
The results are presented below in Table B. In summary, feed intake and body weight were not affected by KIC supplementation. Cows fed KIC had higher milk yields (+5% , p<2 ) , with a higher percent milk fat (+4% , p< .04 ) than control cows. The resulting milk fat yield was increased 10% (p<.02) above the controls. Milk from cows fed KIC also tended to contain less cholesterol than milk from controls. Nitrogen balance data suggests more efficient utilization of dietary nitrogen by KIC-treated animals.
Example III Laying Chickens
Laying hens (69 weeks of age) were randomly assigned to either a control diet or a diet containing 0.2 wt % KIC (Na). For the next 28 days feed consumption was recorded and eggs collected. Eggs were weighed and analyzed for egg yolk cholesterol. The feed composition is shown in Table C and the results in Table D. The total protein was about 18% on a dry matter basis, and the amount of leucine was about 9% of the protein. The control diet was the same except for the omission of the KIC.
TABLE C
Ingredients lbs/1000 lbs.
KIC (Na salt) 2.0
Corn (fine ground) 672.5
Soyabean meal (48% protein) 214.0
Meat & bone meal (50% protein) 20.0
Animal fat 15.0
Limestone (powder) 60.0
Dicalcium phosphate 10.0
D,L methionine 0.5
Vitamin premix 5.0
Salt & trace minerals 3.0
TABLE D
Avg . yoIk
Average No. Feed Average Av. Eggs Cholesterol
No. Birds Eggs/Hen (gms/hen/day) (kg. /hen) (mg/100 gms)
16 Control 17.7 109 1.105 1068
16 Fed KIC 19.5 109 1.233 996
% Change +10.2 0 +11.1 -7 The foregoing diet with KIC is indicated as a desirable ration for commercial use to increase egg production with the same amount of feed, and/or to reduce egg yolk cholesterol.
Example IV Study of Immune Function
A study was conducted to determine if KIC administration can alter white blood cell function, specifically T lymphocyte function, in growing sheep and cattle. Eighteen medium-framed crossbred male lambs were used in experiment 1. Lambs were randomly assigned to either a control diet (n=10) or a diet supplemented with 1% KIC (n=8). Animals were fed ad libitum in individual cages. At 100 and 108 days of treatment, 50-ml blood samples were collected for lymphocyte and neutrophil function tests.
In experiment 2, 19 intact crossbred male lambs were randomly assigned to either a saline treatment group (n=9) or a KIC treatment group (n=10). Control lambs were injected with 50 ml of a saline solution, and KIC treated lambs were injected with 50 ml of a 5% solution of KIC (sodium salt) daily (~2.5 g KIC/day). All injections were made intraperitoneally in the right posterior abdominal region after disinfection of the area. At day 60 and day 66 of treatment, blood was collected for lymphocyte and neutrophil function tests.
In experiment 3 72 castrated male cattle were allotted to 12 pens of 6 animals each. Three pens were assigned to each treatment: 0.0% KIC, 0.02% KIC, 0.07% KIC, and 0.20% KIC. Animals were fed ad libitum the respective diets for 6 weeks. At the end of the 6-week periods, 100-ml blood samples were collected from each animal, and lymphocyte and neutrophil function were evaluated.
Sheep in experiments 1 and 2 were fed diets based on a mixture of 48% corn, 5% molasses, 20% alfalfa meal, 0.8% limestone, 0.6% salt-mineral-vitamin mix and ~25% of a protein supplement (either soybean meal, corn gluten meal, or corn gluten feed). The diets were isonitrogenous and analyzed to be -20% crude protein and 89% dry matter. The KIC diet consisted of the basal diet to which was added 1% calcium-KIC, whereas the control diet was the basal diet plus 0.25% calcium carbonate.
The basal cattle diet (experiment 3) consisted of 49% corn, 24% corn-cobs, 18% soybean meal, 7% molasses, 1.3% limestone, 0.25% dicalcium phosphate, 0.23% salt, 0.02% tracemineral premix, and 0.11% vitamin premix. The basal diet was supplemented with w/w 0.05% control pellets, 0.04% KIC pellets or 0.4% KIC pellets. All animals consumed ~10 kg of feed per day, resulting in ~0, 2, 7, or 20 g of Ca-KIC consumed per animal per day or 0, .02, .07, and .2% KIC of the total diet.
KIC pellets were made by mixing zein, ethanol, KIC, limestone, bentonite, and water in a ratio of 8.3:7.4:5.2:3: 2.1. This mixture was extruded through a die of 15 mm directly into a vat of liquid nitrogen. The shattered pellets were spread out and allowed to air-dry for 2 days. The pellets were coated with zein (2% w/w) bv spraying with a 30% zein solution made in 80% ethanol. The pellets again were air-dryed. Control pellets were made similarly to the KIC pellets except that the mixture was zein, limestone, ethanol, bentonite, and water in a ratio of 12:12:7.5:2.7:1. When KIC pellets were placed in the rumen (nylon bag technique), 33% of the KIC added was present in the bags after 24 hr of rumen fermentation. It was estimated that uncoated KIC was 95% degraded in the rumen.
Blood was collected by jugular venapuncture into acid-citrate-dextrose anticoagulant. Lymphocytes and neutrophils were isolated, and lymphocyte blastogenesis and neutrophil function evaluated. KIC was obtained from SOBAC, Paris, France. Zein was purchased from Freeman Industries, Tuckahoe, NY. Each experiment was statistically analyzed by analysis of variance. In sheep experiments, individual animals were the experimental units, whereas pen means were analyzed in the cattle experiment. The changes in lymphocyte blastogenesis are summarized in Table F. In all three experiments, average background blastogenesis was increased in KIC-treated groups.
Addition of phytohemagglutinin (PHA) to the cells increased 3H-thymidine incorpor-ation 10 to 30-fold over background incorporation. In experiments 1, 2, and 3, KIC increased PHA stimulation by 280%, 150%, and from 8 to 85%, respectively. KIC increased Concanavalin A (ConA) stimulation of blastogenesis in cattle in a quadratic dose-responsive manner. No ConA stimulation occurred in sheep from either experiment. Similarly, KIC enhanced pokeweek mitogen (PWM) activity in cattle but not sheep fed KIC diets (quadratic effect). No significant changes in total white blood cell numbers or in the percentage that were segmented neutrophils were measured. The percentage of eosinophils tended to increase in sheep and cattle fed KIC, whereas they decreased in sheep injected with KIC. The percentage of lymphocytes was increased in experiment 2 and in the 0.02 and 0.07% KIC treated groups in experiment 3.
KIC did not alter neutrophil random migration, Staphylococcus aureus ingestion, cytochrome C reduction, iodination, or antibody-dependent cell-mediated cytotoxicity in any experiment, indicating that KIC does not alter neutrophil function. Feed intake in control and KIC-treated animals was not different in any experiment.
Example V Study of KIC Effect on Cortisol
To determine if KIC could acutely alter cortisol concentrations, young pigs were fed meals supplemented with leucine or KIC and plasma cortisol was measured.
In experiment 1, sixteen female pigs weighing 20-30 kg were used. Seven days before study, catheters were surgically placed in the right atria for blood sampling. Animals were housed in individual cages during the recovery period and had free access to water. Preceding the experiment, animals were fed twice daily a basal diet (2% of body weight per feeding). The basal diet consisted of a corn-soybean mix, adequate in all minerals and vitamins and containing approximately 14% crude protein. Test meals were formulated by additions to a basal diet. Five animals received the basal diet (control); five animals received the leucine meal, which had 2% leucine added to the basal diet; and six animals received the KIC diet, which had 2% KIC (sodium salt equivalent to 1.7% free acid) added to the basal diet. Studies were begun between 0800 and 0900 h after a 24-hr fast. Basal blood samples were taken at -20, -10 and -5 min. Animals were then offered 100 g of their respective test meal (time 0). Pigs were included in the study only if they consumed the entire meal in the first 20 min. Blood was sampled every 30 min from 120 to 240 min. Plasma was separated, Trasylol (FBA Pharmaceuticals, New York, NY) added (50 ul/ml), and plasma stored at -70C until analyzed.
Cortisol was measured by coated tube kits (Gammacoat, Travenol-Genetech Diagnostics, Cambridge, MA). Leucine and KIC were measured by high pressure liquid chromatography. Crystalline leucine was obtained from Sigma Chemical (St. Louis, MO) and KlC-sodium was obtained from . OBAC (Paris, France). Statistical analysis of the individual pig responses was conducted on mean plasma concentrations before the meal (-20 to 0 min) and after the meal (120 to 240 min). When the overall treatment F-value was significant, differences between individual treatments were determined using the pooled SEM and a T-test.
Table G presents the changes in plasma leucine, KIC and cortisol concentration in pigs before and after ingestion of control, leucine and KIC meals. Ingestion of the control meal resulted in a small significant increase in leucine concentration while plasma KIC concentration remained constant. Ingestion of the leucine meal caused plasma leucine concentration to increase 4 fold whereas KIC ingestion caused a doubling of leucine concentration. Plasma KIC concentration increased from a basal concentration of ~40μM to 90 μM and over 100 μM in pigs fed KIC- and leucine-supplemented meals, respectively.
Plasma cortisol concentration did not change after the control meal (Table G). The addition of leucine to the diet resulted in a small decrease in plasma cortisol (-14%, nonsignificant). Addition of KIC to the diet, however, resulted in a 40% decrease in cortisol concentration by 240-300 minutes after the meal (p<.01).
EXAMPLE VI Feedlot Steers
Seventy-two medium-frame steers, with an average weight of 578 lbs., were allotted to 12 pens of 6 animals each. A common basa,l diet was fed ad libitum to all cattle. This consisted of 48.9% cracked corn, 24.4% ground corn cobs, 17.8% expeller Soybean meal, 7.0% molasses (liquid), 1.3% limestone, .25% dicalcium phosphate, 2% salt, .02% trace mineral premix, and .1% vitamin A premix for the first 58 days of the experiment, and was changed to 54.3% cracked corn and 12.8% expeller soybean meal for the remaining 103 days of the experiment. Three pens were assigned to each treatment. The treatments consisted of four levels of Ca-KIC in a pelleted supplement: 0%, 0.02%, 0.07%, and 0.20% of the basal diet (0.05% control pellets, 0.04% KIC pellets, 0.14% KIC pellets, and 0.40% KIC pellets). The pellets were preweighted and top-dressed on the basal diet twice daily. After 58 days, the cattle on the 0.20% KIC were removed from the experiment. The cattle were not implanted with a growth promotant nor were ionophores included in the diet. The cattle were placed in the feedlot and fed a growing ration for 5 weeks prior to the start of the experiment. The cattle were weighed on 2 consecutive days at the beginning and end of the experiment, and every 14 days during the trial. The cattle were sold through a commercial beef processing plant when they were appraised by visual examination to grade Choice. Loin eye area and fat thickness over the loin were measured on each carcass. Quality and yield grades, and percent kidney, heart, and lepvic (KHP) fat were estimated by the federal graders.
Preliminary experiments indicated that uncoated KIC was 95% degraded in the rumen. Therefore, an attempt was made to protect KIC from ruminal degradation. KIC pellets, resistant to rumen degradation, were made by mixing zein, ethanol, KIC, limestone, bentonite and water in a ratio of 8.3:7.4:5.2: 3:2:1. This mixture was extruded through a die of 15 mm directly into a vat of liquid nitrogen. The shattered pellets were spread out and allowed to air-dry for two days. The dried pellets were coated with zein (2% w/w) by spraying with a 30% zein solution made in 80% ethanol. The pellets again were air-dried. Control pellets were made similar to the KIC pellets except that the mixture was zein, limestone, ethanol, bentonite and water in a ratio of 12:12:7.5:2.7:1. When KIC pellets were placed in the rumen (nylon bag technique), 45% of the KIC added was present in the bags after 36 hr of rumen digestion.
KIC was obtained from SOBAC, Paris, France. Zein was purchased from Freeman Industries, Tuckahoe, N.Y. Each experiment was statistically analyzed by analysis of variance with three pens per treatment.
Results and Discussion
1. During the first 58 days of the trial, daily gain was increased by 20% (p<.07), 11% (NS) , and 14% (p<.18) for the 0.02%, 0.07% and 0.20% KIC treatments, respectively (Table H). Daily feed intake was not significantly altered. Feed conversion was improved 13% (p<.05), 9% (p<.17), and 10%
(p<.ll) for the 0.02%, 0.07%, and 0.20% KIC treatments, respectively. Performance response to KIC occurred relatively shortly after KIC was administered, with the greatest response at 0.02% KIC.
2. Over the entire 161-day trial, daily gain was increased by 14% (p<.01) and 7% (NX) for the 0.02% and 0.07% KIC treatments, respectively (Table I). Daily feed intake tended to be increased with increasing gains. Feed conversion was improved 8% (NS) and 6% (NS) for the 0.02% and 0.07% KIC treatments, respectively. While response to KIC was greater in the first 56 days of the trial, a significant response was maintained over the duration of the trial. The 0.02% KIC treatment continued to provide the greatest response, but again, the optimal dose may be below this level.
3. Carcass weight, dressing percent, loin eye area, backfat thickness, KHP fat, and yield grade were not altered by the addition of KIC to the diet. However, the number of cattle grading choice was increased by the addition of KIC to the diet.
4. One steer in the control group died and one steer was treated for sickness, whereas no animals from the KIC-treated groups died or were treated. There was one condemned liver in the control group and one in the 0.07% KIC treatment group.
5. While economic conditions will vary with time, the return per head in this trial was $50 greater for the KIC treated animals due to the increased gain and the greater number of cattle grading choice.
Summarizing, over a long-term trial, feeding KIC to growing steers increased daily gain up to 14% and improved feed conversion up to 8%, while increasing the number of carcasses grading choice. These factors, plus KIC's enhancement of immune function, demonstrates that KIC may have significant potential as a feed additive for growing feedlot cattle.
TABLE H
Steer Performance (58 days)
% Dietary KIC
Item 0.2 0.07 0.20
Starting wt., lb. 578 578 577 580
Ending wt., lb. 756 786 770 779
Daily gain, lb. 2.80 3.36* 3.12 3.19
Daily intake, lb DM/day 16.0 16.8 16.3 16.3
Feed/Gain 5.7 5.0** 5.2 5.2
*p<.1 **p<.05 TABLE I. Steer Performance (161 Days)
% Dietary KIC
Item 0 0.02 0.07
Starting wt., lb. 578 578 577 Ending wt., lb. 1016 1068 1035 Daily gain, lb. 2.66 3.03*** 2.85 Daily intake, lb DM/day 21.2 22.6 21.6 Feed/Gain 8.0 7.4 7.5 ***p<.01

Claims

CLAIMS I claim:
1. The method of improving the commercial performance of domestic animals, comprising feeding alpha-ketoisocaproate (KIC) to the animals in admixture with animal feed, said KIC being in a form nutritionally utilizable by the animal and being fed in an amount enhancing the blastogenesis of the animals' T lymphocytes and/or reducing the animals plasma cortisol.
2. The method of claim 1 in which said domestic animals are mammals selected from the group consisting of cattle, shaep, goats, and swine.
3. The method of claim 1 in which said domestic animals are poultry being raised for meat production.
4. The method of claim 1 in which said domestic animals are cattle being raised for meat production.
5. The method of claim 1 in which said domestic animals are dairy cattle .
6. The method of claim 1 in which said domestic animals are poultry being raised for meat production.
7. The method of claim 1 in which said domestic animals are laying chickens being raised for egg production.
8. The method of claim 1 in which said domestic animals are offspring-nursing female mammals.
9. The method of claim 1 in which said domestic animals are sheep being raised for meat production.
10. The method of favorably altering immune function of domestic animals, comprising administering alpha-ketoisocaproate (KIC) to the animals, said KIC being in a form nutritionally utilizable by the animals and being administered in an amount enhancing blastogenesis of the animals T lymphocytes.
11. The method of counteracting stress-associated immunosuppression in domestic animals, comprising administering alpha-ketoisocaproate (KIC) to the animals, said KIC being in a form nutritionally utilizable by the animals and being administered in an amount reducing the animals plasma cortisol.
12. A feed composition for improving the commercial performance of domestic animals, said composition being composed of feed ingredients admixed with a nutritionally-utilizable form of alpha-ketoisocaproate (KIC).
13. The feed composition of claim 12 in which said composition comprises a complete feed providing substantially all the nutritional requirements of the animals, said KIC being admixed therewith in an amount effective for enhancing the blastogenesis of the animals T lymphocytes and also reducing the animals plasma cortisol, said feed composition containing not over 12 weight percent leucine based on the dry weight of the protein therein.
14. The feed composition of claim 12 comprising a complete feed providing substantially all the nutritional requirements of the animals, said composition containing a molar amount of KIC corresponding to 0.01 to 2.0 weight percent of sodium KIC, and said feed composition containing less than 10 weight percent leucine based on the dry weight of the protein therein.
15. The feed compositions of claims 12, 13, and 14 in which said KIC is sodium KIC.
16. The feed compositions of claims 12, 13, and 14 in which said KIC is calcium KIC.
17. The method of improving the commercial performance of young cattle being raised for meat production, comprising feeding alpha-ketoisocaproate (KIC) to the cattle in admixture with cattle feed, said KIC being in a form nutritionally utilizable by the cattle and being fed in a rumen-protected form corresponding on a molar basis to 2 to 200 milligrams of sodium KIC per kilogram of body weight per 24 hours, the total feed consumed by said cattle containing not over 12% leucine based on the dry weight of the protein therein.
18. The method of improving the commercial perform ance of dairy cattle, comprising feeding alpha-ketoisocaproate (KIC) to the dairy cattle in admixture with dairy cattle feed, said KIC being in a form nutritionally utilizable by the dairy cattle and being fed in a rumen-protected form an amount corresponding to 2 to 200 milligrams of sodium KIC per kilogram of body weight per 24 hours.
19. The method of improving the commercial performance of young chickens being raised for meat production, comprising feeding alpha-ketoisocaproate (KIC) to the chickens in admixture with chicken feed, said KIC being in a form nutritionally utilizable by the chickens and being fed in an amount corresponding to at least 0.01 to 0.05 weight percent of sodium KIC based on the dry weight of the total feed of the chickens, said total feed containing less than 12% leucine based on the dry weight of the total protein therein.
20. The method of improving the commercial performance of laying chickens, comprising feeding alpha-ketoisocaproate (KIC) to the chickens in admixture with chicken feed, said KIC being in a form nutritionally utilizable by the chickens and being fed in an amount at least corresponding to 0.01 to 0.05 weight percent of sodium KIC based on the dry weight of the total feed of the chickens, said total feed containing less than 12% leucine based on the dry weight of the total protein therein.
21. The method of improving the commercial performance of mature sheep being raised for wool production, comprising feeding alpha-ketoisocaproate (KIC) to the sheep in admixture with sheep feed, said KIC being in a form nutritionally utilizable by the sheep and being fed in a rumen-protected form corresponding on a molar basis to 2 to 200 milligrams of sodium KIC per kilogram of body weight per 24 hours, the total feed received by said sheep containing not over 12% leucine based on the dry weight of the total protein therein.
22. The method of improving the commercial performance of veal calves, comprising feeding alpha-ketoisocaproate (KIC) to the veal calves in admixture with veal calf feed, said KIC being in a form nutritionally utilizable by the animals and being fed in an amount corresponding to 2 to 100 milligrams sodium KIC per 100 gms of body weight per 24 hours, the total feed received by said veal calves containing not over 12% leucine based on the dry weight of the total protein.
23. The method of claims 18, 19, 20, 21 and 22 in which said KIC is selected from the group consisting of sodium KIC and calcium KIC, and the total feed received by the animals contains less than 10% leucine based on the total dry weight of the protein therein.
24. The method of claims 19 and 20 in which said KIC is sodium KIC, and the total feed received by the animals contains less than 10% leucine based on the dry weight of the total protein therein.
EP87901996A 1986-03-11 1987-03-09 Immunomodulator for improving commercial performance of domestic animals Ceased EP0258422A1 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US06/838,356 US4758593A (en) 1986-03-11 1986-03-11 Method of feeding ketoisocaproate to lactating domestic mammals
US06/838,357 US4760090A (en) 1986-03-11 1986-03-11 Method of feeding ketoisocaproate to cattle and sheep
US06/838,355 US4764531A (en) 1986-03-11 1986-03-11 Method of feeding ketoisocaproate to laying chickens
US838356 1986-03-11
US838355 1986-03-11
US838357 1986-03-11

Publications (2)

Publication Number Publication Date
EP0258422A4 EP0258422A4 (en) 1988-02-01
EP0258422A1 true EP0258422A1 (en) 1988-03-09

Family

ID=27420276

Family Applications (1)

Application Number Title Priority Date Filing Date
EP87901996A Ceased EP0258422A1 (en) 1986-03-11 1987-03-09 Immunomodulator for improving commercial performance of domestic animals

Country Status (4)

Country Link
EP (1) EP0258422A1 (en)
JP (1) JPS63502835A (en)
AU (1) AU7162987A (en)
WO (1) WO1987005506A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2623824A (en) * 1951-07-05 1952-12-30 Ayerst Mckenna & Harrison Growth promoting agent
US2879162A (en) * 1956-10-04 1959-03-24 Du Pont Augmenting poultry feed

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Journal of Dairy Science, Vol. 69, Suppl. 1, 1986, page 111, Champaign, Ill, US; M.J. VANDEHAAR: "Effect of feeding alpha-ketoisocaproate to dairy cows on milk production", page 111, Abstract P60G. *
See also references of WO8705506A1 *

Also Published As

Publication number Publication date
EP0258422A4 (en) 1988-02-01
JPS63502835A (en) 1988-10-20
WO1987005506A1 (en) 1987-09-24
AU7162987A (en) 1987-10-09

Similar Documents

Publication Publication Date Title
US5028440A (en) Method of raising meat producing animals to increase lean tissue development
US5087472A (en) Feed compositions for domestics animals containing hydroxymethylbutyrate
US4711897A (en) Animal feed methods and compositions using cysteamine
US4835185A (en) Immunomodulator for improving commercial performance of domestic animals
US4760090A (en) Method of feeding ketoisocaproate to cattle and sheep
EP0104630B1 (en) Animal growth promotant and method of use for animal growth
JP2542655B2 (en) Mixed feed for animals
US4534969A (en) Method for improving lactation in ruminant animals
EP0237956B1 (en) Method of feeding ketoisocaproate to lactating domestic mammals
US4454137A (en) Feed compositions containing copper salts of 2-hydroxypyridine-N-oxides
US4258031A (en) Feed composition containing ronnel and antibiotic A3823 complex and use thereof
US4414206A (en) Animal feeds
EP0258422A1 (en) Immunomodulator for improving commercial performance of domestic animals
EP0596026A1 (en) Antibiotic feed compositions and method of enhancing feed efficiency and promoting growth in monogastic animals
US4462995A (en) Pyridyl phosphorothioate compositions and their use as anabolic agents
JPS63238020A (en) Bacillus polymyxa containing drug for livestock administration
EP0080854A1 (en) Method of improving growth of poultry
US3719758A (en) Method of promoting growth and improving feed efficiency in poultry and swine via oral administration of cephalosporin c
WO1995022259A1 (en) Improving growth and lactation of ruminants
CA1296636C (en) 2-pyridinol compounds useful as anabolic agents
Nissen Method of feeding ketoisocaproate to cattle and sheep
US3978221A (en) Methods for improving the feed intake of meat producing animals
WO2020243975A1 (en) Use of nutraceutical composition in animal feed
JPH01320956A (en) Growth promoting agent of domestic animals
EP0166025A2 (en) Non-antibiotic animal feed additive compositions

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): DE FR GB IT NL

A4 Supplementary search report drawn up and despatched

Effective date: 19880201

17P Request for examination filed

Effective date: 19880322

17Q First examination report despatched

Effective date: 19910702

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 19920926

RIN1 Information on inventor provided before grant (corrected)

Inventor name: NISSEN, STEVEN, L.